These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1787640)

  • 1. Elimination of Candida albicans from kidneys of mice during short-term systemic infections.
    Baghian A; Lee KW
    Kidney Int; 1991 Sep; 40(3):400-5. PubMed ID: 1787640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic candidosis in silica-treated athymic and euthymic mice.
    Lee KW; Balish E
    Infect Immun; 1983 Sep; 41(3):902-7. PubMed ID: 6309672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans.
    Vecchiarelli A; Cenci E; Marconi P; Rossi R; Riccardi C; Bistoni F
    J Med Microbiol; 1989 Nov; 30(3):183-92. PubMed ID: 2511321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic candidosis in beige mice.
    Baghian A; Lee KW
    J Med Vet Mycol; 1989; 27(1):51-5. PubMed ID: 2666633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein.
    Londono LP; Jones HB; Vie AT; McPheat WL; Booth G; Gao XM; Dougan G
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):117-25. PubMed ID: 10640606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of germfree mice to systemic candidosis.
    Lee KW; Balish E
    J Reticuloendothel Soc; 1981 Mar; 29(3):241-8. PubMed ID: 7012339
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental Candida albicans infection in conventional mice and germfree rats.
    Rogers T; Balish E
    Infect Immun; 1976 Jul; 14(1):33-8. PubMed ID: 780278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired immunity to systemic candidiasis in immunodeficient mice.
    Cantorna MT; Balish E
    J Infect Dis; 1991 Nov; 164(5):936-43. PubMed ID: 1940472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome.
    Mahanty S; Greenfield RA; Joyce WA; Kincade PW
    Infect Immun; 1988 Dec; 56(12):3162-6. PubMed ID: 3182076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of splenic macrophage Candida albicans phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice.
    Algarra I; Ortega E; Serrano MJ; Alvarez de Cienfuegos G; Gaforio JJ
    FEMS Immunol Med Microbiol; 2002 Jul; 33(3):159-63. PubMed ID: 12110477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of host defence against bacterial and fungal infections of mice pretreated with the non-pathogenic Escherichia coli strain Nissle 1917.
    Hockertz S
    Arzneimittelforschung; 1997 Jun; 47(6):793-6. PubMed ID: 9239462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen.
    Tansho S; Ab S; Mizutani S; Ono Y; Takesako K; Yamaguchi H
    Microbiol Immunol; 2002; 46(5):307-11. PubMed ID: 12139389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo determination of phagocytic indices and candidacidal activities of Candida species by rat peritoneal macrophages.
    Salim R; van Gelderen de Komaid A
    Mycopathologia; 1986 Jul; 95(1):17-23. PubMed ID: 3531869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
    Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
    Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans.
    Choi JH; Ko HM; Kim JW; Lee HK; Han SS; Chun SB; Im SY
    J Immunol; 2001 Apr; 166(8):5139-44. PubMed ID: 11290796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution in mice of intravenously administered labelled Candida albicans.
    Trnovec T; Sikl D; Zemánek M; Faberová V; Bezek S; Gajdosík A; Koprda V
    Sabouraudia; 1978 Dec; 16(4):299-306. PubMed ID: 377524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of T-cells and intestinal bacteria on resistance of mice to candidosis.
    Lee KW; Balish E
    J Reticuloendothel Soc; 1982 Mar; 31(3):233-40. PubMed ID: 7042972
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.
    Bistoni F; Vecchiarelli A; Mazzolla R; Puccetti P; Marconi P; Garaci E
    Antimicrob Agents Chemother; 1985 Apr; 27(4):625-31. PubMed ID: 3890731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced susceptibility of burned mice to experimental infection with Candida albicans.
    Law EJ; Lee KL; Tewari RP
    Mykosen; 1984 Nov; 27(11):562-72. PubMed ID: 6395014
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of nucleotide restriction and supplementation on resistance to experimental murine candidiasis.
    Fanslow WC; Kulkarni AD; Van Buren CT; Rudolph FB
    JPEN J Parenter Enteral Nutr; 1988; 12(1):49-52. PubMed ID: 3278158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.